These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9243618)

  • 41. Detailed mapping of serotonin 5-HT1B and 5-HT1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function.
    Bonaventure P; Voorn P; Luyten WH; Jurzak M; Schotte A; Leysen JE
    Neuroscience; 1998 Jan; 82(2):469-84. PubMed ID: 9466454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The non-peptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigs.
    Phebus LA; Johnson KW; Stengel PW; Lobb KL; Nixon JA; Hipskind PA
    Life Sci; 1997; 60(18):1553-61. PubMed ID: 9126877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists.
    Zhang D; Kohlman D; Krushinski J; Liang S; Ying BP; Reilly JE; Dinn SR; Wainscott DB; Nutter S; Gough W; Nelson DL; Schaus JM; Xu YC
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6011-6. PubMed ID: 15546719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic 5-HT
    García-Pedraza JÁ; Hernández-Abreu O; García M; Morán A; Villalón CM
    Can J Physiol Pharmacol; 2018 Apr; 96(4):328-336. PubMed ID: 28886249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery of 4-[3-(trans-3-dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]-(4S)-oxazolidin-2-one (4991W93), a 5HT(1B/1D) receptor partial agonist and a potent inhibitor of electrically induced plasma extravasation.
    Jandu KS; Barrett V; Brockwell M; Cambridge D; Farrant DR; Foster C; Giles H; Glen RC; Hill AP; Hobbs H; Honey A; Martin GR; Salmon J; Smith D; Woollard P; Selwood DL
    J Med Chem; 2001 Mar; 44(5):681-93. PubMed ID: 11262079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CP-93,129, a potent and selective 5-HT1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea-pig dura mater.
    Matsubara T; Moskowitz MA; Byun B
    Br J Pharmacol; 1991 Sep; 104(1):3-4. PubMed ID: 1664765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Further characterization of the 5-hydroxytryptamine 5-HT1-like receptor mediating contraction of guinea-pig iliac artery.
    Schoeffter P; Sahin-Erdemli I
    Eur J Pharmacol; 1992 Aug; 219(2):295-301. PubMed ID: 1425955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.
    Pullar IA; Boot JR; Broadmore RJ; Eyre TA; Cooper J; Sanger GJ; Wedley S; Mitchell SN
    Eur J Pharmacol; 2004 Jun; 493(1-3):85-93. PubMed ID: 15189767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Naratriptan has a selective inhibitory effect on trigeminovascular neurones at central 5-HT1A and 5-HT(1B/1D) receptors in the cat: implications for migraine therapy.
    Boers PM; Donaldson C; Zagami AS; Lambert GA
    Cephalalgia; 2004 Feb; 24(2):99-109. PubMed ID: 14728705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 4-Hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: selective h5-HT1D agonists for the treatment of migraine.
    Bourrain S; Neduvelil JG; Beer MS; Stanton JA; Showell GA; MacLeod AM
    Bioorg Med Chem Lett; 1999 Dec; 9(23):3369-74. PubMed ID: 10612601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological characterization of 5-hydroxytryptamine4(5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives.
    Bockaert J; Sebben M; Dumuis A
    Mol Pharmacol; 1990 Mar; 37(3):408-11. PubMed ID: 2314390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
    Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
    Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is selective 5-HT
    Rubio-Beltrán E; Labastida-Ramírez A; Villalón CM; MaassenVanDenBrink A
    Pharmacol Ther; 2018 Jun; 186():88-97. PubMed ID: 29352859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Co-localization of 5-HT(1B/1D/1F) receptors and glutamate in trigeminal ganglia in rats.
    Ma QP
    Neuroreport; 2001 Jun; 12(8):1589-91. PubMed ID: 11409721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Co-localization of 5-HT1B- and 5-HT1D receptor mRNA in serotonergic cell bodies in guinea pig dorsal raphé nucleus: a double labeling in situ hybridization histochemistry study.
    Bonaventure P; Langlois X; Leysen JE
    Neurosci Lett; 1998 Sep; 254(2):113-6. PubMed ID: 9779933
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-HT(1F) Receptor agonists: a new treatment option for migraine attacks?
    Neeb L; Meents J; Reuter U
    Neurotherapeutics; 2010 Apr; 7(2):176-82. PubMed ID: 20430316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.
    Shepheard S; Edvinsson L; Cumberbatch M; Williamson D; Mason G; Webb J; Boyce S; Hill R; Hargreaves R
    Cephalalgia; 1999 Dec; 19(10):851-8. PubMed ID: 10668103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum.
    Carter D; Champney M; Hwang B; Eglen RM
    Eur J Pharmacol; 1995 Jul; 280(3):243-50. PubMed ID: 8566092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization.
    Millan MJ; Newman-Tancredi A; Lochon S; Touzard M; Aubry S; Audinot V
    Pharmacol Biochem Behav; 2002 Apr; 71(4):589-98. PubMed ID: 11888550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.